During the past decade, Kaiser Permanente conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 34 clinical trials were completed, i.e. on average, 109.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 17 clinical trials were completed. i.e. 154.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente" #1 sponsor was "Gilead Sciences" with 18 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Kaiser Permanente" with 8 trials sponsored, "NICHD Pelvic Floor Disorders Network" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "Genentech, Inc." with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "University of Alabama at Birmingham" with 5 trials as a collaborator and "University of California, San Diego" with 5 trials as a collaborator. Other collaborators include 78 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente" are "Breast Cancer" (12 trials), "Hepatitis C, Chronic" (5 trials), "Chronic Hepatitis C" (4 trials), "Pelvic Organ Prolapse" (4 trials) and "Overactive Bladder" (3 trials). Many other conditions were trialed in "Kaiser Permanente" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente" are "Drug" (60 trials), "Device" (14 trials), "Other" (9 trials), "Procedure" (9 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (7 trials), "Placebo" (7 trials), "Docetaxel" (6 trials), "Paclitaxel" (6 trials) and "Doxorubicin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente" are 58 trials for "All" genders, 26 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente". undefined are not yet recruiting, 7 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in Kaiser Permanente, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".